Aims & scope
JPBS publishes pharmaceutical research that links formulation and drug delivery to biological, therapeutic or clinical performance.
The Journal of Pharmaceutical and Biomedical Sciences is dedicated to advancing pharmaceutical science through the development, characterisation and evaluation of pharmaceutical formulations and drug-delivery systems with demonstrable biological, therapeutic or clinical relevance.
The journal focuses on the relationship between pharmaceutical design and therapeutic performance, with particular emphasis on how formulation strategies, pharmaceutical technologies and drug-delivery approaches can improve drug stability, solubility, bioavailability, targeting, efficacy, safety and clinical applicability.
A central objective is to promote research that goes beyond formulation development alone and demonstrates how pharmaceutical interventions influence biological function or therapeutic outcomes. Studies are especially encouraged when they clearly link formulation or pharmaceutical technology to biological performance and therapeutic benefit.
Scope
The journal primarily covers research in pharmaceutics, pharmaceutical technology, drug delivery and biopharmaceutics, along with closely related areas that directly contribute to the development, optimisation, evaluation or therapeutic application of pharmaceutical products.
The scope includes, but is not limited to, the areas listed below. Interdisciplinary contributions are welcome only when pharmaceutical science remains the central focus of the research. Biomedical, pharmacological, microbiological, molecular, materials-science or clinical investigations are within scope when they directly support the development, characterisation, mechanism, evaluation or therapeutic application of a pharmaceutical product or delivery system.
- Pharmaceutics and pharmaceutical formulation: preformulation, formulation development, dosage-form design, excipient selection and functionality, physicochemical characterisation, stability, optimisation, scale-up and quality-by-design approaches.
- Drug-delivery systems: conventional and modified-release systems, controlled and sustained release, targeted delivery, transdermal and topical delivery, oral and mucosal delivery, injectable and implantable systems, and other advanced delivery approaches.
- Nanopharmaceuticals and advanced delivery systems: nanoparticles, liposomes, lipid-based carriers, polymeric systems, micelles, nanostructured systems, hydrogels and other pharmaceutical delivery platforms, particularly when their pharmaceutical and therapeutic performance is evaluated.
- Biopharmaceutics and pharmacokinetics: drug absorption, distribution, transport, bioavailability, bioequivalence, drug release, permeability, pharmacokinetic–pharmacodynamic relationships, and factors that influence therapeutic exposure.
- Pharmaceutical technology: manufacturing and processing technologies, formulation optimisation, process development, product characterisation, stability-indicating approaches, and innovative technologies for pharmaceutical product development.
- Pharmaceutical evaluation and therapeutic performance: studies evaluating the relationship between formulation characteristics and pharmacological, biological, toxicological or therapeutic outcomes, including efficacy, safety, tolerability and therapeutic index.
- Pharmaceutical nanotechnology and biomaterials: pharmaceutical applications of nanomaterials, biomaterials and functional materials when developed for drug delivery, pharmaceutical formulation or therapeutic applications.
- Natural products and phytopharmaceuticals: formulation, standardisation, delivery, bioavailability enhancement, stability improvement and therapeutic evaluation of natural products and plant-derived bioactive compounds.
- Pharmaceutical biotechnology and biologics: formulation and delivery of biologics, peptides, proteins, vaccines and other biotechnology-derived therapeutic agents, with emphasis on pharmaceutical stability, delivery, bioavailability and therapeutic performance.
- Pharmaceutical approaches to antimicrobial therapy: formulation and delivery of antimicrobial agents, enhancement of antimicrobial efficacy, combination and delivery strategies, and pharmaceutical approaches aimed at improving treatment of infectious diseases and addressing antimicrobial resistance.
- Pharmaceutical analysis and characterisation: analytical and bioanalytical methods directly related to pharmaceutical formulation, drug delivery, drug release, stability, bioavailability, pharmacokinetics and characterisation of pharmaceutical systems.
- Computational pharmaceutical research: molecular modelling, molecular docking, computational drug–excipient or drug–target studies, and predictive approaches that are directly connected to pharmaceutical formulation, drug delivery, or experimentally validated therapeutic applications.
- Translational pharmaceutics: pharmaceutical research that demonstrates a clear progression from formulation or drug-delivery design to biological, pharmacological, preclinical or clinical outcomes.
What the journal prioritises
The journal prioritises studies that demonstrate a clear relationship between pharmaceutical design, formulation or delivery, biological performance, and therapeutic or clinical relevance.
The Journal of Pharmaceutical and Biomedical Sciences seeks to provide a focused platform for pharmaceutical research that demonstrates not only how a pharmaceutical system is developed but also why its design matters for biological and therapeutic performance.
Out of scope
Research that is purely biomedical, clinical, microbiological, molecular or materials-science oriented, without a substantive pharmaceutical component, falls outside the journal’s primary scope.
The journal does not consider work whose primary purpose is marketing a product, or manuscripts that withhold the method needed to test the claim.